reglab/statecodes huggingface dataset:
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-18 - PRESCRIPTIONS OF CERTAIN MEDICINAL DRUGS BY PHARMACISTS › Section 64B15-18.003 - Medicinal Drugs Which May be Ordered by Pharmacists

Current through Reg. 50, No. 138; July 16, 2024
A Pharmacist may order and dispense from the following
				  formulary within the pharmacist's professional judgment, subject to the stated
				  conditions:
(1) Oral analgesics for
				mild to moderate pain. The pharmacist may order these drugs for minor pain and
				menstrual cramps for patients with no history of peptic ulcer disease. The
				prescription shall be limited to a six (6) day supply for one treatment. If
				appropriate, such prescriptions shall be labeled to be taken with food or milk.
(a) Magnesium salicylate/phenyltoloxamine
				citrate.
(b) Acetylsalicylic acid
				(Zero order release, long acting tablets).
(c) Choline salicylate and magnesium
				salicylate.
(d) Naproxen
				sodium.
(e) Naproxen.
(f) Ibuprofen.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-18 - PRESCRIPTIONS OF CERTAIN MEDICINAL DRUGS BY PHARMACISTS › Section 64B15-18.004 - Fluoride Containing Products

Current through Reg. 50, No. 138; July 16, 2024
Oral medicinal drug products containing fluoride may be
				  ordered by pharmacists for their patients who do not have fluoride supplement
				  in their drinking water, pursuant to the following limitations:
(1) The fluoride content of drinking water
				does not exceed 0.5 ppm.
(2) Once a
				fluoride treatment has been initiated with one specific fluoride medicinal drug
				product it should not be interchanged with a product of a different
				manufacturer for the course of the treatment.
(3) If the fluoride content is less than 0.5
				ppm then the following dosage schedule for oral usage shall be followed:
(a)
1. For
				ages 0-6 months.
a. Less than 0.3 ppm in
				water - no supplementation.
b. 0.3
				- 0.6 ppm in water - no supplementation.
c. 0.6 ppm in water - no
				supplementation.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-19 - DISCIPLINARY GUIDELINES › Section 64B15-19.001 - Purpose

Current through Reg. 50, No. 138; July 16, 2024
The board provides within this rule chapter disciplinary
				  guidelines which shall be imposed upon applicants or licensees whom it
				  regulates under Chapter 459, F.S., or telehealth providers registered under
				  Section  456.47(4), F.S.
				  The purpose of this rule chapter is to notify applicants and licensees of the
				  ranges of penalties which will routinely be imposed during a formal or informal
				  hearing unless the board finds it necessary to deviate from the stated
				  guidelines. Each range includes the lowest and highest penalty and all
				  penalties falling between. For purposes of this rule chapter, the order of
				  penalties, ranging from lowest to highest, is: letter of concern; reprimand;
				  probation; fine; restriction or certification with restrictions; suspension,
				  revocation or refusal to certify. For telehealth registrants, a suspension may
				  be accompanied by a corrective action plan that includes rehabilitative
				  provisions narrowly tailored to address the conduct which resulted in the
				  underlying disciplinary violations. The Board may require a corrective action
				  plan to be completed prior to reinstatement of the suspended registration or
				  the corrective action plan may follow a suspension for a definite term.
				  Pursuant to Section  459.015(2),
				  F.S., combinations of these penalties are permissible by law. Nothing in this
				  rule chapter shall preclude any discipline imposed upon an applicant or
				  licensee pursuant to a stipulation or settlement agreement, nor shall the
				  stated ranges of penalties preclude the probable cause panel from issuing a
				  letter of guidance upon a finding of probable cause where
				  appropriate.
Rulemaking Authority
					 456.079,
					 459.005,
					 459.015(5) FS.
					 Law Implemented 456.079
					 FS.
New 9-30-87, Formerly 21R-19.001, 61F9-19.001, 59W-19.001,
					 Amended 2-2-98, 11-12-00, 11-24-20.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-19 - DISCIPLINARY GUIDELINES › Section 64B15-19.003 - Aggravating or Mitigating Circumstances

Current through Reg. 50, No. 138; July 16, 2024
When either the petitioner or respondent is able to
				  demonstrate aggravating or mitigating circumstances to the board by clear and
				  convincing evidence, the board shall be entitled to deviate from the above
				  guidelines in imposing discipline upon an applicant or licensee. Absence of any
				  such evidence of aggravating or mitigating circumstances before the hearing
				  officer prior to the issuance of a recommended order shall not relieve the
				  board of its duty to consider evidence of mitigating or aggravating
				  circumstances. Aggravating and mitigating circumstances shall include, but not
				  be limited to the following:
(1) The
				danger to the public;
(2) The
				length of time since the violations;
(3) The number of times the licensee has been
				previously disciplined by the Board;
(4) The length of time the licensee has
				practiced;
(5) The actual damage,
				physical or otherwise, caused by the violation;
(6) The deterrent effect of the penalty
				imposed;
(7) The effect of penalty
				upon the licensee's livelihood;
(8)
				Any effort of rehabilitation by the licensee;
(9) The actual knowledge of the licensee
				pertaining to the violation;
(10)
				Attempts by the licensee to correct or stop violations or refusal by licensee
				to correct or stop violations;
(11)
				Related violations against licensee in another state, including findings of
				guilt or innocence, penalties imposed and penalties served;
(12) The actual negligence of the licensee
				pertaining to any violations;
(13)
				The penalties imposed for related offenses;
(14) The pecuniary gain to the
				licensee;
(15) Any other relevant
				mitigating or aggravating factors under the circumstances. Any penalties
				imposed by the board may not exceed the maximum penalties set forth in Section
				 459.015(2),
				F.S.
Rulemaking Authority
					 456.079 FS. Law Implemented
					 456.079
					 FS.
New 9-30-87, Formerly 21R-19.003, 61F9-19.003, 59W-19.003,
					 Amended 7-13-04.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-19 - DISCIPLINARY GUIDELINES › Section 64B15-19.004 - Time for Payment of Civil Penalties

Current through Reg. 50, No. 138; July 16, 2024
In cases where the Board of Osteopathic Medicine imposes a
				  civil penalty for violation of Chapter 456 or 459, F.S., or the rules
				  promulgated pursuant thereunder, the penalty shall be paid within thirty (30)
				  days of its imposition by Order of the Board unless stated otherwise in the
				  Order.
Rulemaking Authority
					 456.072(4),
					 459.005 FS. Law Implemented
					 456.072(4),
					 FS.
New 12-23-80, Formerly 21R-11.02, 21R-11.002, 21R-19.004,
					 61F9-19.004, 59W-19.004, Amended
					 11-12-00.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-19 - DISCIPLINARY GUIDELINES › Section 64B15-19.0041 - Standard Terms Applicable to Orders

Current through Reg. 50, No. 138; July 16, 2024
Unless otherwise approved by the Board or its designee, or
				  addressed by the Final Order, the following are the terms applicable to all
				  Final Orders rendered by the Board in disciplinary proceedings.
(1) Payment of Fines and Costs. All fines and
				costs shall be paid by check or money order made payable to the Board and sent
				to DOH/Compliance Management Unit, Bin #C76, P.O. Box 6320, Tallahassee,
				Florida 32314-6320, within 30 days of the filing of the Order.
(2) Addresses. Respondent must keep current
				residence and practice addresses on file with the Board. Respondent shall
				notify the Compliance Office, in writing, within 10 days of any changes of
				those addresses. Furthermore, if the Respondent's license is on probation, the
				Respondent shall notify the Compliance Office within 10 days in the event that
				Respondent leaves the active practice of medicine in Florida.
(3) Compliance Address. All reports,
				correspondence and inquiries shall be sent to: DOH, Compliance Management Unit,
				Bin #C76, 4052 Bald Cypress Way, Tallahassee, Florida 32399-3251, Attn:
				Osteopathic Medicine Compliance Officer.
(4) Continuing Education. Continuing
				education imposed by Board Order shall be in addition to those hours required
				for biennial renewal of licensure. The Board confers authority on the Chair to
				approve or disapprove said continuing education courses. The Respondent is
				required to submit a course syllabus for all continuing education courses that
				the Respondent needs to have the Chair approve. The courses shall consist of a
				formal live lecture format. The time frame for completing such continuing
				education follows:
(a) Florida Medical
				Association sponsored medical records course or Board approved equivalent is to
				be completed within twelve (12) months from the date the Order is
				filed;
(b) University of Florida
				sponsored prescribing course or Board-approved equivalent is to be completed
				within twelve (12) months from the date the Order is filed; and,
(c) Continuing medical education is to be
				completed within twelve (12) months from the date the order is
				filed.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-19 - DISCIPLINARY GUIDELINES › Section 64B15-19.005 - Probationary Conditions and Definitions and Practice Restrictions

Current through Reg. 50, No. 138; July 16, 2024
(1) Indirect Supervision. Whenever a license
				is placed on probation or otherwise restricted in such a manner as to require
				the Respondent to practice under indirect supervision, the term indirect
				supervision does not require that the monitoring physician practice on the same
				premises as the Respondent; however, the monitor shall practice within a
				reasonable geographic proximity to Respondent, which shall be within 20 miles
				unless otherwise authorized by the Board, and shall be readily available for
				consultation.
(2) Direct
				Supervision. Whenever a license is placed on probation or otherwise restricted
				in such a manner as to require the Respondent to practice under direct
				supervision, the term direct supervision requires that the Respondent practice
				medicine only if the supervisor is on the premises.
(3) Provisions governing all supervised or
				monitored physicians.
(a) The
				supervisor/monitor shall be furnished with copies of the Administrative
				Complaint, Final Order, Stipulation (if applicable), and other relevant
				orders.
(b) The Respondent shall
				not practice without a supervisor/monitor unless otherwise ordered by the
				Board. The Respondent shall appear at the next meeting of the Board with his
				proposed supervisor or monitor unless otherwise ordered.
(c) After the next meeting of the Board,
				Respondent shall only practice under the supervision of the supervisor or
				monitor. If for any reason the approved supervisor/monitor is unwilling or
				unable to serve, Respondent and the supervisor/monitor shall immediately notify
				the Executive Director of the Board, and Respondent shall cease practice until
				a temporary supervisor/monitor is approved. The Chairman of the Board may
				approve a temporary supervisor/monitor who may serve in that capacity until the
				next meeting of the Board at which time the Board shall accept or reject a new
				proposed supervisor/monitor. If the Board rejects the proposed
				supervisor/monitor, Respondent shall cease practice until a new
				supervisor/monitor is approved by the Board.
(d) The supervisor/monitor must be a licensee
				under Chapter 459 or 458, F.S., in good standing and without restriction or
				limitation on his license. In addition, the Board may reject any proposed
				supervisor/monitor on the basis that he or she has previously been subject to
				any disciplinary action against his or her license to practice osteopathic
				medicine in this or any other jurisdiction. The supervisor/monitor must be
				actively engaged in the same or similar specialty area unless otherwise
				provided by the Board. The Board may also reject any proposed
				supervisor/monitor for good cause shown.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-19 - DISCIPLINARY GUIDELINES › Section 64B15-19.006 - Supervision of Physician Assistant

Current through Reg. 50, No. 138; July 16, 2024
No Physician whose license to practice medicine has been
				  placed on probation shall, during the term of probation, serve as a Primary
				  Supervising Physician or Alternate Supervising Physician, or in any other
				  supervisory capacity, to a Physician Assistant.
Rulemaking Authority
					 459.005,
					 459.022 FS. Law Implemented
					 459.015(2)(g),
					 459.022(2)(f)
					 FS.
New 4-18-89, Formerly 21R-19.006, 61F9-19.006,
					 59W-19.006.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-19 - DISCIPLINARY GUIDELINES › Section 64B15-19.008 - Mediation

Current through Reg. 50, No. 138; July 16, 2024
(1) The provisions set forth in subsection
				(2), below, shall qualify for mediation only when the violation can be remedied
				by the licensee and there is no intentional misconduct.
(2) The Board finds that the following
				offenses may be mediated if the offense meets the criteria of Section
				 456.078,
				F.S.:
(a) False, deceptive or misleading
				advertising not involving intentional misconduct;
(b) Failure to comply with the requirements
				of Sections  381.026 and
				 381.0261, F.S., to provide
				patients with information about their patient rights and how to file a patient
				complaint;
(c) Failure to provide,
				upon request, patient records to a patient or a patient's legal
				representative;
(d) Negligently
				failing to file a report or record required by state or federal law;
(e) Falsely certifying compliance with
				required continuing medical education hours for the purpose of renewing a
				license or certification;
(f)
				Failure to verify profile information or failure to comply with the
				requirements for profiling and credentialing;
(g) Failure to notify the Department of
				change of practice or mailing address;
(h) Charging copying fees for patient records
				in violation of Rule  64B15-15.003, F.A.C.;
				and,
(i) Failure to pay the fines
				or costs imposed by Board order.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-19 - DISCIPLINARY GUIDELINES › Section 64B15-19.009 - Submission of Malpractice Record

Current through Reg. 50, No. 138; July 16, 2024
(1)
				All physicians licensed pursuant to Chapter 459, F.S., shall provide the Board
				of Osteopathic Medicine a copy of the record of any finding of medical
				malpractice resulting from a civil or administrative proceeding involving an
				incident that occurred on or after November 2, 2004 within 180 days of entry of
				the final judgment or order, or within 180 days of the effective date of this
				rule, whichever is later. The record shall be sent to the Board of Osteopathic
				Medicine, 4052 Bald Cypress Way, BIN-CO6, Tallahassee, Florida 32399.
(2) The record shall include the official
				transcript of the civil or administrative proceeding resulting in a finding of
				medical malpractice, excluding any jury selection transcript, all evidence
				admitted or copies of evidence if original is not available, those matters
				officially recognized by the civil or administrative tribunal, and the final
				order or judgment reported or issued by the tribunal.
(3) The record shall be provided to the Board
				on a read only CD ROM disc in portable document format (.pdf) or tagged image
				file format (.tif).
Rulemaking Authority
					 456.50(2) FS.
					 Law Implemented 456.50(2)
					 FS.
New 7-31-07.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-20 - FINANCIAL RESPONSIBILITY › Section 64B15-20.002 - Definitions

Current through Reg. 50, No. 138; July 16, 2024
The term "patient contact hours," as used in Section
				  459.0085(5)(f)2., F.S., means the number of hours during which the physician is
				  available to see patients or is performing patient care activities, including,
				  but not limited to, completing patient records and reviewing laboratory
				  reports.
Rulemaking Authority
					 459.005,
					 459.0085 FS. Law Implemented
					 459.0085
					 FS.
New 10-28-87, Formerly 21R-20.002, 61F9-20.002,
					 59W-20.002.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-20 - FINANCIAL RESPONSIBILITY › Section 64B15-20.003 - Procedures

Current through Reg. 50, No. 138; July 16, 2024
(1)
(a) At
				the time a person seeks initial licensure or reactivation of an inactive
				license that person or his employer must show compliance with the requirements
				of Section  459.0085, F.S., before a
				license, or an active license, respectively, shall be issued.
(b) During the license renewal period of each
				biennium, an application for renewal will be mailed to each licensee at the
				last address provided to the Board. Failure to receive any notification during
				this period does not relieve the licensee of the responsibility of meeting the
				financial responsibility or license renewal requirements.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-20 - FINANCIAL RESPONSIBILITY › Section 64B15-20.004 - Exemptions for Persons Not Practicing in Florida; Change of Status

Current through Reg. 50, No. 138; July 16, 2024
(1)
(a)
				Persons who are not practicing medicine in Florida may be exempt from
				compliance with the financial responsibility requirements pursuant to Section
				459.0085(5)(b), (licensees with inactive licenses) or 459.0085(5)(e),
				(licensees with active licenses), F.S., as follows:
(b) A licensee who has claimed an exemption
				based on the fact that the license is inactive and the licensee is not
				practicing medicine in Florida and who applies for reactivation of the medical
				license must, in addition to the other requirements for reactivation, either
				show that he or she maintained tail insurance for the time periods prescribed
				by the statute or submit an affidavit stating that he or she has no unsatisfied
				medical malpractice judgments or settlements at the time of application for
				reactivation;
(c) A licensee who
				has claimed an exemption based on the fact that, although an active license has
				been maintained, the licensee has not been practicing medicine in Florida must,
				before initiating or resuming the practice of medicine in this state, notify
				the Department of the intent to practice in the state and show compliance with
				the requirements of the financial responsibility law or show exemption
				therefrom in the manner set forth in Rule  64B15-20.003, F.A.C.;
(d) A licensee who is both reactivating an
				inactive license and initiating or resuming the practice of medicine in Florida
				must meet the requirements of both subsections (a) and (b),
				above.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-22 - REGISTRATION OF HOSPITAL RESIDENTS AND INTERNS › Section 64B15-22.001 - Definitions

Current through Reg. 50, No. 138; July 16, 2024
(1) An unlicensed physician is a person
				holding a degree as a Doctor of Osteopathic Medicine from a college of
				osteopathic medicine recognized and approved by the American Osteopathic
				Association but not licensed by the Board of Osteopathic Medicine. For the
				purpose of administering this rule chapter, such unlicensed physicians shall
				embrace and include interns, residents, and fellows as these terms are defined
				herein.
(2) An intern is a
				physician with an osteopathic medical degree or its equivalent who is
				continuing his training. This training ordinarily follows immediately upon the
				granting of the doctor of osteopathic medicine degree. The term "intern" also
				means a first year resident or post graduate year one physician.
(3) A resident osteopathic physician is one
				who has completed an internship and is engaged in a program of training
				designed to increase his knowledge of the clinical disciplines of medicine,
				surgery or any of the other special fields which provide advanced training in
				preparation for the practice of a specialty. In the years following the
				internship, the person is usually referred to as a resident
				physician.
(4) A fellow is an
				osteopathic physician who is engaged in a program of training leading to a
				subspeciality board certification or certificate of added
				qualification.
Specific Authority
					 459.005,
					 459.021(7) FS.
					 Law Implemented 459.021
					 FS.
New 10-28-91, Amended 1-3-93, Formerly 21R-22.001,
					 61F9-22.001, 59W-22.001, Amended
					 1-19-98.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-22 - REGISTRATION OF HOSPITAL RESIDENTS AND INTERNS › Section 64B15-22.002 - Duties of an Intern

Current through Reg. 50, No. 138; July 16, 2024
An internship consists of the supervised care of patients in
				  a hospital and in its out-patient department, with continued instruction in the
				  science and art of osteopathic medicine by the hospital staff. The
				  physician-student is given the opportunity to put into practice the principles
				  of preventive medicine, diagnosis, therapy, and patient management which he
				  learned as a medical student. He is able to observe patients on an "around the
				  clock" basis and can follow patients from admission to discharge and
				  subsequently in the out-patient department. Under the supervision of the
				  attending staff, he is given progressively increasing responsibility to the end
				  that he acquires confidence in his own clinical judgment. For the training to
				  be approved, the hospital where the internship is served must be approved by
				  the American Osteopathic Association, or by the Board.
Specific Authority
					 459.005,
					 459.021 FS. Law Implemented
					 459.021
					 FS.
New 10-28-91, Formerly 21R-22.002, 61F9-22.002,
					 59W-22.002.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-22 - REGISTRATION OF HOSPITAL RESIDENTS AND INTERNS › Section 64B15-22.003 - Duties of a Resident Osteopathic Physician

Current through Reg. 50, No. 138; July 16, 2024
A resident physician participates in an organized post
				  graduate educational program in which he has daily contact with patients and
				  assumes increasing responsibility for their care under the supervision of the
				  attending staff of the hospital. The assumption of responsibility is a most
				  important aspect of residency training. As each resident physician demonstrates
				  increasing knowledge and ability, an increasing amount of reliance should be
				  placed in his judgment in the diagnosis and in treatment of patients. He may
				  also participate in the teaching of interns and medical students to an
				  increasing extent. In surgery and surgical specialties, the resident physician
				  should be given ample opportunity to perform major surgical procedures under
				  direct supervision of qualified members of the professional staff of the
				  hospital, particularly in the later stages of his training, in order that he
				  may acquire surgical skill and judgment.
Specific Authority
					 459.005,
					 459.021 FS. Law Implemented
					 459.021
					 FS.
New 10-28-91, Formerly 21R-22.003, 61F9-22.003,
					 59W-22.003.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15-22 - REGISTRATION OF HOSPITAL RESIDENTS AND INTERNS › Section 64B15-22.004 - Mandatory Registration of Unlicensed Physicians

Current through Reg. 50, No. 138; July 16, 2024
Registration as a resident, intern, or fellow shall be
				  accomplished by completing the board approved application form, DH-MQA 1172
				  (Revised 5/22), Osteopathic Physician in Training Application for Initial or
				  Renewal Registration pursuant to Section
				   459.021, F.S., which is hereby
				  incorporated by reference, and may be obtained from
http://www.flrules.org/Gateway/reference.asp?No=Ref-14608
,
				  from the Board of Osteopathic Medicine, 4052 Bald Cypress Way, Bin #C06,
				  Tallahassee, Florida 32399-3256, or from the website at:
https://floridasosteopathicmedicine.gov/
.
Rulemaking Authority
					 459.005,
					 459.021 FS. Law Implemented
					 459.021
					 FS.
New 10-28-91, Amended 1-3-93, Formerly 21R-22.004,
					 61F9-22.004, 59W-22.004, Amended 1-19-98, 6-28-09, 4-15-10, 9-16-10, 3-26-12,
					 8-1-13, 9-11-16, 10-28-19, 9-15-20, 4-4-21,
					 9-13-22.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15ER23 - EMERGENCY RULE FOR YEAR 2023 › Section 64B15ER23-4 - Sex-reassignment Prescriptions

Current through Reg. 50, No. 138; July 16, 2024
A patient's prescribing physician may renew a prior lawfully
				  issued sex-reassignment prescription as defined in section
				   456.001(9)(a),
				  Florida Statutes, that was prescribed prior to May 17, 2023, up and until six
				  months from the effective date of the Board's emergency rule formally adopting
				  a consent form per sections
				   456.52(1) and
				  (2), Florida Statutes.
Rulemaking Authority
					 456.52(1)(a),
					 (b),
					 456.52(6)(a)
					 FS. Law Implemented  456.52(1), (2) 
					 FS.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15ER23 - EMERGENCY RULE FOR YEAR 2023 › Section 64B15ER23-9 - Sex-reassignment Standards of Practice in Minors

Current through Reg. 50, No. 138; July 16, 2024
The standards of practice in this rule do not supersede the
				  level of care, skill, and treatment recognized in general law related to
				  healthcare licensure.
(1) Pursuant to
				Section  456.52, Florida Statutes,
				sex-reassignment prescriptions and procedures are prohibited for patients
				younger than 18 years of age, except that a physician may continue to treat
				such patient with a prescription if such treatment for sex-reassignment was
				commenced before, and is still active on, May 17, 2023. The physician is
				required to obtain voluntary, informed consent while physically present in the
				same room as the patient. Consent is not required for renewal of such
				prescriptions if a physician and his or her patient have met the requirements
				for consent for the initial prescription or renewal; however, a separate
				consent is required for any new prescription for a pharmaceutical product not
				previously prescribed to the patient.
(2) Informed Consent. The Board has approved
				the following mandatory informed consent forms for the continued treatment of
				minors with sex-reassignment prescriptions:
(a) For patients prescribed puberty blocking
				medications, form DH5079-MQA, (06/23), entitled "Puberty Suppression Treatment
				for Patients with Gender Dysphoria, Patient Information and Informed Parental
				Consent and Assent for Minors," which is hereby incorporated by reference and
				available from the Board's website at
https://flboardofmedicine.gov/forms/Puberty-Suppression-Treatment-for-Patients-with-Gender-Dysphoria-Patient-Information-and-Parental-Consent-and-Assent-for-Minors.pdf
.
(b) For patients prescribed sex-reassignment
				feminizing medications, form DH5080-MQA, (06/23), entitled "Feminizing
				Medications for Patients with Gender Dysphoria, Patient Information and
				Informed Parental Consent and Assent for Minors," which is hereby incorporated
				by reference and available from the Board's website at
https://flboardofmedicine.gov/forms/Feminizing-Medications-for-Patients-with-Gender-Dysphoria-Patient-Information-and-Parental-Consent-and-Assent-for-Minors.pdf
.
(c) For patients prescribed sex-reassignment
				masculinizing medications, form DH5081-MQA, (06/23), entitled "Masculinizing
				Medications for Patients with Gender Dysphoria, Patient Information and
				Informed Parental Consent and Assent for Minors," which is hereby incorporated
				by reference and available from the Board's website at
https://flboardofmedicine.gov/forms/Masculinizing-Medications-for-Patients-with-Gender-Dysphoria-Patient-Information-and-Parental-Consent-and-Assent-for-Minors.pdf
.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15ER23 - EMERGENCY RULE FOR YEAR 2023 › Section 64B15ER23-10 - Mandatory Standardized Informed Consent for Sex-reassignment Prescriptions or Procedures in Adults

Current through Reg. 50, No. 138; July 16, 2024
Pursuant to Section
				   456.52, Florida Statutes, when
				  sex-reassignment prescriptions or procedures are prescribed for or administered
				  or performed on patients 18 years of age or older, the physician is required to
				  obtain voluntary, informed consent while physically present in the same room as
				  the patient. Consent is not required for renewal of such prescriptions if a
				  physician and the physician's patient have met the requirements for consent for
				  the initial prescription or renewal; however, a separate consent is required
				  for any new prescription for a pharmaceutical product not previously prescribed
				  to the patient.
(1) Informed Consent.
				The Board has approved the following mandatory informed consent forms for
				sex-reassignment prescriptions or procedures for patients 18 years of age or
				older:
(a) For patients prescribed
				sex-reassignment feminizing medication, form DH5082-MQA, (06/23), entitled
				"Feminizing Medications for Patients with Gender Dysphoria, Patient Information
				and Informed Consent," which is hereby incorporated by reference and available
				from the Board's website at
https://flboardofmedicine.gov/forms/Feminizing-Medications-for-Patients-with-Gender-Dysphoria-Patient-Information-and-Informed-Consent.pdf
.
(b) For patients prescribed sex-reassignment
				masculinizing medications, form DH5083-MQA, (06/23), entitled "Masculinizing
				Medications for Patients with Gender Dysphoria, Patient Information and
				Informed Consent," which is hereby incorporated by reference and available from
				the Board's website at
https://flboardofmedicine.gov/forms/Masculinizing-Medications-for-Patients-with-Gender-Dysphoria-Patient-Information-and-Informed-Consent.pdf
.
(c) For patients undergoing surgical
				treatment, form DH5084-MQA, (06/23), entitled "Surgical Treatment for Adults
				with Gender Dysphoria, Patient Information and Informed Consent," which is
				hereby incorporated by reference and available from the Board's website at
https://flboardofmedicine.gov/forms/Surgical-Treatment-for-Adults-with-Gender-Dysphoria-Patients-Information-and-Informed-Consent.pdf
.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B15 - Board of Osteopathic Medicine › Chapter 64B15ER23 - EMERGENCY RULE FOR YEAR 2023 › Section 64B15ER23-12 - Mandatory Standardized Informed Consent for Sex-reassignment Prescriptions or Procedures in Adults

Current through Reg. 50, No. 138; July 16, 2024
Pursuant to Section
				   456.52, Florida Statutes, when
				  sex-reassignment prescriptions or procedures are prescribed for or administered
				  or performed on patients 18 years of age or older, the physician is required to
				  obtain voluntary, informed consent while physically present in the same room as
				  the patient. Consent is not required for renewal of such prescriptions if a
				  physician and the physician's patient have met the requirements for consent for
				  the initial prescription or renewal; however, a separate consent is required
				  for any new prescription for a pharmaceutical product not previously prescribed
				  to the patient.
(1) Informed Consent.
				The Board has approved the following mandatory informed consent forms for
				sex-reassignment prescriptions or procedures for patients 18 years of age or
				older:
(a) For patients prescribed
				sex-reassignment feminizing medication, form DH5082-MQA, (Rev. 08/23), entitled
				"Feminizing Medications for Patients with Gender Dysphoria, Patient Information
				and Informed Consent," which is hereby incorporated by reference and available
				from the Board's website at
https://flboardofmedicine.gov/forms/Feminizing-Medications-for-Patients-with-Gender-Dysphoria-Patient-Information-and-Informed-Consent.pdf
.
(b) For patients prescribed sex-reassignment
				masculinizing medications, form DH5083-MQA, (Rev. 08/23), entitled
				"Masculinizing Medications for Patients with Gender Dysphoria, Patient
				Information and Informed Consent," which is hereby incorporated by reference
				and available from the Board's website at
https://flboardofmedicine.gov/forms/Masculinizing-Medications-for-Patients-with-Gender-Dysphoria-Patient-Information-and-Informed-Consent.pdf
.
(c) For patients undergoing surgical
				treatment, form DH5084-MQA, (06/23), entitled "Surgical Treatment for Adults
				with Gender Dysphoria, Patient Information and Informed Consent," which is
				hereby incorporated by reference and available from the Board's website at
https://flboardofmedicine.gov/forms/Surgical-Treatment-for-Adults-with-Gender-Dysphoria-Patients-Information-and-Informed-Consent.pdf
.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-25 - ORGANIZATION AND PURPOSE › Section 64B16-25.130 - Executive Director (Repealed)

Current through Reg. 50, No. 138; July 16, 2024
Rulemaking Authority
					 465.005 FS. Law Implemented
					 48.111(2),
					 456.004,
					 456.009
					 FS.
New 10-17-79, Formerly 21S-8.04, 21S-8.004, Amended
					 7-30-91, Formerly 21S-25.130, 61F10-25.130, 59X-25.130, Amended 10-29-97,
					 11-2-03, Repealed 3-28-12.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-25 - ORGANIZATION AND PURPOSE › Section 64B16-25.170 - Probable Cause Panel

Current through Reg. 50, No. 138; July 16, 2024
(1) The
				determination as to whether probable cause exists to believe that a violation
				of Chapter 456, Part II, 465, 499 or 893, F.S., or of the rules promulgated
				thereunder, has occurred shall be made by the probable cause panel. The panel
				shall meet as necessary.
(2) The
				probable cause panel shall be composed of two (2) persons, either current or
				former board members appointed by the chairman of the Board. One appointee must
				be a current board member. The panel must include a former or current board
				member who is a licensed pharmacist. An appointee may be a former board
				member.
Rulemaking Authority
					 465.005 FS. Law Implemented
					 456.073
					 FS.
New 10-17-79, Formerly 21S-8.08, 21S-8.008, 21S-25.170,
					 61F10-25.170, 59X-25.170, Amended
					 11-24-09.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-25 - ORGANIZATION AND PURPOSE › Section 64B16-25.340 - Meetings and Workshops

Current through Reg. 50, No. 138; July 16, 2024
The following are considered to be official meetings of the
				  Board:
(1) Board Meetings.
(2) Examination Committee Meetings.
(3) Tripartite Continuing Education Committee
				Meeting.
(4) Meetings of committees
				set out in the official minutes of the Board where statutory authority is given
				by the practice act.
(5) Meetings
				of a Board member with Department staff or contractors of the Department at the
				Department's or Board's request. Any participation or meeting of members
				noticed or unnoticed will be on file in the Board office.
(6) Where a Board member has been requested
				by the State Surgeon General to participate in a meeting.
(7) Probable Cause Panel meetings.
(8) All activity of Board members, if
				authorized by the Board, when grading, proctoring or reviewing examinations
				given by the Department.
(9) All
				participation in Board authorized meetings with professional associations of
				which the Board is a member or invitee. This would include all meetings of the
				National Association of Boards of Pharmacy of which the Board is a member as
				well as Board authorized participation in meetings of national or professional
				associations or organizations involved in educating, regulating and reviewing
				the profession over which the Board has statutory authority.
(10) Any and all other activities which are
				Board approved and which are necessary for Board members to attend in order to
				further protect the public health, safety and welfare, through the regulation
				of which the Board has statutory authority.
Rulemaking Authority
					 456.011(4) FS.
					 Law Implemented 456.011(4)
					 FS.
New 9-30-81, Amended 11-13-81, 12-31-81, Formerly
					 21S-10.05, 21S-10.005, Amended 7-30-91, Formerly 21S-25.340, 61F10-25.340,
					 59X-25.340, Amended 2-18-08.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-26 - PHARMACISTS LICENSURE › Section 64B16-26.100 - Pharmacists Newly Licensed (Repealed)

Current through Reg. 50, No. 138; July 16, 2024
Rulemaking Authority
					 456.013(2),
					 465.005 FS. Law Implemented
					 456.013(2),
					 465.008
					 FS.
New 3-19-79, Formerly 21S-6.04, Amended 1-7-87, 12-29-88,
					 10-16-90, Formerly 21S-6.004, Amended 1-10-93, Formerly 21S-26.100,
					 61F10-26.100, 59X-26.100, Amended 4-17-01, Repealed
					 3-10-05.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-26 - PHARMACISTS LICENSURE › Section 64B16-26.1001 - Examination and Application Fees

Current through Reg. 50, No. 138; July 16, 2024
(1) The
				examination fee for licensure by examination shall be $100, payable to the
				Board. Examination fees for the National Practice Examination and jurisprudence
				examination are payable to the examination vendor.
(2) The non-refundable application fee
				licensure by endorsement shall be $100, payable to the Board.
(3) The application fee for a continuing
				education provider seeking approved provider status shall be $150, payable to
				the Board.
(4) The application fee
				for the Immunization Administration Certification shall be $55 for pharmacists
				and no fee for pharmacy interns, payable to the Board.
(5) The non-refundable application fee for
				registered pharmacy technicians shall be $50, payable to the
				Board.
Rulemaking Authority
					 456.025,
					 465.005,
					 465.077(1)(a),
					 465.0075(1),
					 465.009,
					 465.014(2) FS.
					 Law Implemented  456.025(7),
					  465.007,
					  465.0075,
					  465.009,
					  465.014,
					  465.189 FS.
New 1-11-05, Amended 10-30-07, 11-15-09, 7-7-10,
					 3-14-16.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-26 - PHARMACISTS LICENSURE › Section 64B16-26.1002 - Initial License Fees

Current through Reg. 50, No. 138; July 16, 2024
(1) The initial
				license fee for a pharmacist license shall be $190 plus a $5 unlicensed
				activity fee pursuant to Section
				 456.065(3),
				F.S.
(2) The initial license fee
				for a consultant pharmacist license shall be $50 plus a $5 unlicensed activity
				fee pursuant to Section
				 456.065(3),
				F.S.
(3) The initial license fee
				for a nuclear pharmacist license shall be $50 plus a $5 unlicensed activity fee
				pursuant to Section  456.065(3),
				F.S.
(4) The initial registration
				fee for a registered pharmacy technician shall be $50 plus a $5 unlicensed
				activity fee pursuant to Section
				 456.065(3),
				F.S.
Rulemaking Authority
					 465.005,
					 465.0125,
					 465.0126 FS. Law Implemented
					 456.013(2),
					 456.065(3),
					 465.0125,
					 465.0126,
					 465.014
					 FS.
New 1-11-05, Amended
					 11-24-09.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-26 - PHARMACISTS LICENSURE › Section 64B16-26.1003 - Active License Renewal Fees

Current through Reg. 50, No. 138; July 16, 2024
(1) The
				biennial license renewal fee for an active pharmacist license shall be $200
				plus a $5 unlicensed activity fee pursuant to Section
				 456.065(3),
				F.S.
(2) The biennial license
				renewal fee for a consultant pharmacist active license shall be $100 plus a $5
				unlicensed activity fee pursuant to Section
				 456.065(3),
				F.S.
(3) The biennial license
				renewal fee for a nuclear pharmacist active license shall be $100 plus a $5
				unlicensed activity fee pursuant to Section
				 456.065(3),
				F.S.
(4) The biennial registration
				renewal fee for a registered pharmacy technician shall be $50 plus $5
				unlicensed activity fee pursuant to Section
				 456.065(3),
				F.S.
Rulemaking Authority
					  456.036,
					 465.005,
					 465.008,
					 465.0125,
					 465.0126 FS. Law Implemented
					 456.036,
					  456.065(3),
					  465.008,
					  465.0125,
					  465.0126,
					  465.014 FS.
New 1-11-05, Amended 2-24-10,
					 2-1-12.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-26 - PHARMACISTS LICENSURE › Section 64B16-26.1004 - Inactive License Election; Renewal; Fees

Current through Reg. 50, No. 138; July 16, 2024
(1) A pharmacist
				licensee may elect:
(a) At the time of license
				renewal to place the license on inactive status by submitting a written request
				with the board for inactive status and submitting the inactive status renewal
				fee of $200 plus a $5 unlicensed activity fee pursuant to Section
				 456.065(3),
				F.S.
(b) At the time of license
				renewal, if the license is inactive, to continue the license on inactive status
				by submitting a written request with the board for inactive status and
				submitting the inactive status renewal fee of $200 plus a $5 unlicensed
				activity fee pursuant to Section
				 456.065(3),
				F.S.
(c) At the time of license
				renewal to change the inactive status license to active status, provided the
				licensee meets the continuing education requirements of Rule
				 64B16-26.103, F.A.C., for each
				biennium the license was on inactive status, submits the reactivation fee of
				$70, and the current active renewal fee set forth in Rule
				 64B16-26.1001, F.A.C.
(d) At a time other than license renewal to
				change the inactive status license to active status, provided the licensee
				meets the continuing education requirements of Rule
				 64B16-26.103, F.A.C., for each
				biennium the license was on inactive status and submits the reactivation fee of
				$70, a change of status fee of $25 and the difference between the inactive
				status renewal fee and the active status renewal fee, if any
				exists.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-26 - PHARMACISTS LICENSURE › Section 64B16-26.1005 - Retired License Election; Renewal; Fees

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee may elect
				to place his or her license on retired status.
(a) At the time of license renewal, to place
				the license on retired status, the licensee must submit a written request with
				the board for retired status and submit the retired status fee of $50.00
				pursuant to Section  456.036(4)(b),
				F.S., and the current unlicensed activity fee.
(b) At a time other than license renewal, to
				place the license on retired status, the licensee must submit a written request
				to the Board for the retired status plus submit the retired status fee of
				$50.00 pursuant to Section
				 456.036(4)(b),
				F.S., plus a change of status fee of $25.00, plus the current unlicensed
				activity fee.
(c) Before the
				license of a retired status licensee is reactivated, the licensee must meet the
				continuing education requirements in Rule
				 64B16-26.103, F.A.C., and pay
				any renewal fees imposed on an active status licensee for all biennial
				licensure periods, plus the current unlicensed activity fee during which the
				licensee was on retired status.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-26 - PHARMACISTS LICENSURE › Section 64B16-26.101 - Fees and License Renewal Application (Repealed)

Current through Reg. 50, No. 138; July 16, 2024
Rulemaking Authority
					 465.005 FS. Law Implemented
					 456.036,
					 456.064,
					 465.008
					 FS.
New 3-19-79, Formerly 21S-6.05, Amended 1-7-87, 4-21-87,
					 12-29-88, Formerly 21S-6.005, Amended 7-31-91, 1-10-93, Formerly 21S-26.101,
					 61F10-26.101, Amended 3-10-96, Formerly 59X-26.101, Amended 12-31-97, 12-3-00,
					 3-18-01, 10-15-01, Repealed
					 3-10-05.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-26 - PHARMACISTS LICENSURE › Section 64B16-26.1012 - Approved Continuing Education Provider Renewal Fee

Current through Reg. 50, No. 138; July 16, 2024
The biennial fee to renew as an approved continuing education
				  provider shall be $150.
Rulemaking Authority
					 456.013(9),
					 465.005 FS. Law Implemented
					 456.013(9),
					 465.009,
					 465.012
					 FS.
New 1-11-05.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64B16 - Board of Pharmacy › Chapter 64B16-26 - PHARMACISTS LICENSURE › Section 64B16-26.102 - Inactive License Renewal (Repealed)

Current through Reg. 50, No. 138; July 16, 2024
Rulemaking Authority
					 465.005 FS. Law Implemented
					 465.008,
					 465.012
					 FS.
New 3-19-79, Formerly 21S-6.06, Amended 1-7-87, 12-29-88,
					 Formerly 21S-6.006, Amended 7-31-91, 1-10-93, Formerly 21S-26.102,
					 61F10-26.102, Amended 3-10-96, Formerly 59X-26.102, Amended 3-18-01, Repealed
					 3-10-05.